Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

ProMIS Neurosciences Inc > 30 shares azzyma come on dont be a azzziehat
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(251)
•••
Post by IIIIIIIIIIIIIIlon Jul 08, 2022 8:53pm
223 Views
Post# 34812350

30 shares azzyma come on dont be a azzziehat

30 shares azzyma come on dont be a azzziehat
That was all that sold at 11.51..Just saying I hate l;iars and scammers


2 RBC		 K
15:41:20 D 11.85 0.20 14 124 Questrade 1 Anonymous E
15:41:16 U 11.85 3.63 100 79 CIBC 2 RBC K
15:41:16 T 11.78 3.56 100 79 CIBC 79 CIBC K
15:40:42 P 11.51 -8.09 30 7 TD Sec 9 BMO Nesbitt E
15:40:42 M 11.52 3.30 100 79 CIBC 9 BMO Nesbitt  
15:40:10 M 11.73 3.51 100 7 TD Sec 1 Anonymous  
15:40:10 T 11.87 3.65 100 1 Anonymous 1 Anonymous K
15:40:10 U 11.87 3.65 200 1 Anonymous 2 RBC K
15:39:20 T 11.87 3.65 100 1 Anonymous 2 RBC K
15:36:24 T 11.87 3.65 100 1 Anonymous 2 RBC K
15:36:20 D 11.87 0.20 65 124 Questrade 1 Anonymous E
15:36:19 T 11.87 3.65 100 1 Anonymous 2 RBC K
15:36:11 T 11.80 3.58 100 1 Anonymous 1 Anonymous K
15:36:09 T 11.79 3.57 200 1 Anonymous 79 CIBC K
15:34:27 M 11.485 3.265 100 1 Anonymous 1 Anonymous  
15:33:04 M 11.17 2.95 10 1 Anonymous 80 National Bank  
15:32:40 D 11.87 0.20 95 124 Questrade 2 RBC E
15:32:22 D 11.17 0.20 95 1 Anonymous 124 Questrade E
15:31:32 D 12.00 0.20 91 124 Questrade 1 Anonymous E
15:31:22 H 11.80 3.58 100 1 Anonymous 1 Anonymous K
15:31:15 T 11.80 3.58 200 1 Anonymous 1 Anonymous K
15:30:57 M 12.00 3.78 2 14 ITG 14 ITG  
15:30:48 M 11.915 3.695 200 124 Questrade 1 Anonymous  
15:30:48 D 12.00 0.20 50 124 Questrade 1 Anonymous E
15:30:44 T 11.75 3.53 100 1 Anonymous 79 CIBC K
15:30:43 T 11.75 3.53 100 1 Anonymous 1 Anonymous K
15:30:42 T 11.75 3.53 100 1 Anonymous 1 Anonymous K
15:30:39 T 11.63 3.68 31 33 Canaccord 124 Questrade  
15:30:39 T 11.63 3.68 33 7 TD Sec 7 TD Sec  
15:30:01 M 11.425 3.205 100 79 CIBC 1 Anonymous  
15:30:01 M 11.425 3.205 100 79 CIBC 1 Anonymous  
15:30:01 M 11.425 3.205 100 79 CIBC 1 Anonymous  
15:30:01 M 11.425 3.205 100 79 CIBC 1 Anonymous  
15:28:32 M 11.575 3.355 100 79 CIBC 1 Anonymous  
15:28:32 M 11.575 3.355 100 79 CIBC 1 Anonymous  
15:28:32 M 11.575 3.355 100 79 CIBC 1 Anonymous  
15:28:32 M 11.575 3.355 100 79 CIBC 1 Anonymous  
15:28:31 M 11.575 3.355 100 79 CIBC 1 Anonymous  
15:28:13 T 11.90 3.68 100 1 Anonymous 1 Anonymous K
15:28:13 M 11.575 3.355 100 79 CIBC 1 Anonymous  
15:28:06 D 12.00 0.20 77 124 Questrade 1 Anonymous E
15:27:16 T 11.70 3.48 200 1 Anonymous 2 RBC K
15:27:16 U 11.70 3.48 200 1 Anonymous 2 RBC K
15:27:05 M 11.35 3.13 100 79 CIBC 1 Anonymous  
15:27:05 M 11.35 3.13 100 79 CIBC 1 Anonymous  
15:26:59 T 11.70 3.48 100 124 Questrade 2 RBC K
15:26:47 T 11.69 3.47 400 1 Anonymous 1 Anonymous K
15:26:37 T 11.50 3.28 300 1 Anonymous 124 Questrade K
15:26:37 T 11.50 3.28 200 1 Anonymous 7 TD Sec K
15:26:36 M 11.49 3.27 500 22 Fidelity 1 Anonymous  
15:26:35 M 11.49 3.27 100 79 CIBC 1 Anonymous  
15:26:35 M 11.49 3.27 100 79 CIBC 1 Anonymous  
15:26:35 M 11.49 3.27 100 79 CIBC 1 Anonymous  
15:26:31 T 11.49 3.27 100 1 Anonymous 1 Anonymous K
15:26:29 T 11.50 3.28 100 1 Anonymous 7 TD Sec K
15:26:27 T 11.40 3.18 100 1 Anonymous 1 Anonymous K
15:26:16 T 11.30 3.08 400 1 Anonymous 2 RBC K
15:26:16 U 11.30 3.08 500 1 An
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities